News Mylan expects first US Herceptin biosimilar launch Deal with Roche paves way for near-copy of breast cancer blockbuster
News Mylan challenges Amgen's Neulasta in US Mylan and Biocon file biosimilar of white blood cell booster
News Teva's CEO Vigodman steps down Firm searches for new leader, chairman takes over on interim basis.
News Embattled Mylan files Herceptin biosimilar in US But senators call for investigation into EpiPen schools contracts.
News EMA seeks input on virtual alternative to animal test EMA delivers a milestone in the replacement of animals in drug testing with the qualification of a virtual model for repeat-dose toxicity studies.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
